Clinical Trial

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

Study acronym: CHOICE
Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to evaluate the obstetric and oncological outcomes of patients diagnosed with endometrial adenocarcinoma (EAC) or atypical endometrial hyperplasia (AEH) who underwent conservative treatment at the CLASS Hysteroscopy Center of Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome. Eligible patients include women who received hysteroscopic surgery and hormonal therapy either to preserve fertility or due to medical contraindications to standard radical surgery. Follow-up lasts 12 months.
Trial Details
NCT Number NCT07077876
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Endometrial Adenocarcinoma, Endometrial Hyperplasia, Fertility Preservation, Conservative Treatment Therapy
Enrollment 100 participants
Start Date 2025-06-20
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-01-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-22